Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

The aim of this study was to evaluate the frequency and prognostic impact of changes in the
estrogen (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER2) …

Objective: To investigate the expression discordances of estrogen receptor (ER),
progesterone receptor (PR), human epidermal growth factor receptor2 (HER-2) and Ki-67 in …

In recurrent breast cancer, the tumor phenotype, as assessed by estrogen receptor (ER),
progesterone receptor (PR), and human epidermal growth factor 2 (HER2) status …

The success of current hormonal therapies used in breast cancer patients often depends on
estrogen receptor (ER) status. The simultaneous pathological assessment of primary breast …

Background: Recent studies have shown that the expression status of hormone receptors
and human epidermal growth factor receptor 2 (HER2) in breast cancer may change during …

Background In de novo metastatic breast cancer patients, the site of metastasis and
prognosis are related to the molecular subtype of breast cancer. There are few relevant …

e13095 Background: Biomarker status change have been documented in various studies.
However, data from developing countries are sparse. This study is performed to document …

Background Hormone receptor and HER-2/neu discordance between the primary lesion and
first metastasis has been reported. This study was performed to determine further biomarker …